X-Therma Inc. received 1st place in the fierce top 15 competition to win the 2018 annual SVIEF Star Award. Hundreds of companies competed throughout the recent month and 10,000 investors, entrepreneurs, and Silicon Valley community attended the event. We turn your Sci-Fi dream into reality with XT-ViVo. https://mp.weixin.qq.com/s/uc8XHK1qcp9C-SNTz20Ceg
X-Therma Inc. received 2nd place for the 2018 International Marine Innovation and Entrepreneurship Competition in Qingdao, China for XT-ViVo, the ocean-inspired nanoscience breakthrough to revolutionize the cold chain of regenerative medicine.
Meet us at China-US Entrepreneur & Investment Summit Tomorrow (July 21st at Santa Clara Convention Center). Dr. Mark Kline (CTO of X-Therma) will reveal how X-Therma technology will revolutionize Human Organ Transplants and save millions of lives!
https://www.eventbrite.com/e/
http://www.buffalo.edu/atbuffalo/article-page-summer-2018.host.html/content/shared/www/atbuffalo/articles/Summer-2018/alumni-life/the-big-chill.detail.html
X-Therma CTO Dr. Mark Kline will give an insightful presentation at University of California, Berkeley (UCB) Stem Cell Retreat in Monterey, CA where the frontier stem cell research of UC-Berkeley and others is revealed annually. We are here to help scientists with better solutions to preserve the precious stem cells and engineered organs.
X-Therma was awarded 3rd place (241 teams in Silicon Valley, 1400 teams globally) of “The 2nd China Shenzhen Innovation and Entrepreneurship International Competition”, Silicon Valley division and brought home a prize of RMB 30,000. Congratulations to the Team!
X-Therma CEO Dr. Xiaoxi Wei welcomed her first baby into the world and is proud he became the first donor and “Patient” for X-Therma CORDX program. The medical team at Kaiser Permanente Oakland Medical Center collected the cord blood, cord tissue and placenta from the newborn with X-Therma’s collection kit. The precious cord and placental stem cells and tissues were seamlessly delivered to X-Therma’s facility in Richmond and cryopreserved with the XT-ViVoTM products series in liquid nitrogen (-196℃) following GMP standard practices. The future revival of such stem cells and tissues will benefit from non-toxic XT-ViVoTM solutions with excellent recovery from freezing. X-Therma continues to advance the hope for effective regenerative medicine treatments.
Dr. Mark Kline, Chief Technology Officer of X-Therma will deliver an enchanting entreprenuer story at the American Chemical Society (ACS) Entreprenuer Summit on Nov 15-16th, Washington D.C.
https://www.acs.org/content/acs/en/meetings/acs-entrepreneur-summit.html
X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a section presentation on our new generation of cryoprotectants for the regenerative medicine industry at the CRYO17 Meeting in Hefei, China
X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding to fuel X-Therma’s development to advance critical stem cell manufacturing processes.
